Tirzepatide is a dual GIP and GLP-1 receptor agonist research peptide studied for its role in incretin signaling, metabolic research, appetite-related pathways, and glucose-regulation models. It is of interest in research involving multi-pathway metabolic signaling.
Potential Human Benefits Being Investigated
- Blood-glucose regulation
- A1C reduction in type 2 diabetes research
- Insulin-sensitivity pathways
- Appetite and satiety signaling
- Body-weight reduction research
- Weight-maintenance research
- Reduced food intake/craving-related pathways
- Blood-pressure marker research
- Lipid and cholesterol marker research
- Fasting glucose and fasting insulin research
- Obesity-related inflammation pathways
- Fat-mass reduction research
- Metabolic-syndrome research
- Type 2 diabetes risk-reduction research
- Obstructive sleep apnea research in adults with obesity
- Liver-fat and fatty-liver/metabolic-dysfunction research
